Menu Close

Helsinn is a privately-owned Swiss Pharma Group with an extensive portfolio of marketed innovative cancer and rare disease therapies, a robust drug development pipeline and ambitions to accelerate its growth through in-licensing and acquisitions to address unmet medical needs. Since 1976, Helsinn has been improving the lives of patients, guided by core family values of respect, integrity and quality, through a unique integrated licensing business model, achieving success with long-standing partners in 190 countries, who share our values. Headquartered in Switzerland, with operating subsidiaries in the U.S., China, Monaco and manufacturing sites in Switzerland and Ireland. 

Contact Us